Idiopathic neutropenia of childhood is associated with Fas/FasL expression

被引:5
作者
Nadeau, Kari C. [1 ]
Callejas, Angel [1 ]
Wong, Wendy B. [1 ]
Joh, Jae Won [1 ]
Cohen, Harvey J. [1 ]
Jeng, Michael R. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
关键词
Neutropenia; Apoptosis; Fas; Fas ligand; Idiopathic neutropenia; Pediatric neutropenia; Neutrophil disorder;
D O I
10.1016/j.clim.2008.08.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Idiopathic neutropenia (IN) in children is characterized by decreased neutrophil counts (<1500/mu l), can be acute or chronic (greater than 6 months duration). The pathophysiology is not well understood; therefore, potential mechanisms of pediatric IN were investigated. An increase in Fas transcripts in neutrophits of IN patients compared to age-matched healthy control (HC) neutrophits was observed (p<0.005). Increased expression of Fas protein was found in IN neutrophits, white Fas surface expression on other immune cells was similar. Plasma from acute IN patients had higher protein levels of soluble FasL than chronic IN patients. When HC neutrophits were incubated in plasma from IN patients, greater rates of apoptosis were observed. Biochemical studies suggest the apoptotic factor(s) in plasma is heat-sensitive, non-IgG, and 12-50 kD protein. Addition of anti-sFasL blocking antibodies to patient plasma caused a statistically significant decrease in neutrophil. apoptosis. These studies show that the Fas/FasL pathway could be associated with neutrophil. apoptosis in childhood IN. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:438 / 447
页数:10
相关论文
共 31 条
[1]   Diagnosis and management of chronic neutropenia during childhood [J].
Bernini, JC .
PEDIATRIC CLINICS OF NORTH AMERICA, 1996, 43 (03) :773-&
[2]   Neutrophil antibody specificity in different types of childhood autoimmune neutropenia [J].
Bruin, MCA ;
von dem Borne, AEGK ;
Tamminga, RYJ ;
Kleijer, M ;
Buddelmeijer, L ;
de Haas, M .
BLOOD, 1999, 94 (05) :1797-1802
[3]   Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases [J].
Bux, J ;
Behrens, G ;
Jaeger, G ;
Welte, K .
BLOOD, 1998, 91 (01) :181-186
[4]   Primary and secondary autoimmune neutropenia [J].
Capsoni, F ;
Sarzi-Puttini, P ;
Zanella, A .
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (05) :208-214
[5]   Kostmann syndrome or infantile genetic agranulocytosis, part two:: understanding the underlying genetic defects in severe congenital neutropenia [J].
Carlsson, Goran ;
Melin, Malin ;
Dahl, Niklas ;
Ramme, Kim Goransdotter ;
Nordenskjold, Magnus ;
Palmblad, Jan ;
Henter, Jan-Inge ;
Fadeel, Bengt .
ACTA PAEDIATRICA, 2007, 96 (06) :813-819
[6]  
Carlsson G, 2006, HAEMATOLOGICA, V91, P589
[7]   Neutropenia associated with primary immunodeficiency syndromes [J].
Cham, B ;
Bonilla, MA ;
Winkelstein, J .
SEMINARS IN HEMATOLOGY, 2002, 39 (02) :107-112
[8]   G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms [J].
Donini, Marta ;
Fontana, Stefania ;
Savoldi, Gianfranco ;
Vermi, William ;
Tassone, Laura ;
Gentili, Francesca ;
Zenaro, Elena ;
Ferrari, Daniela ;
Notarangelo, Lucia D. ;
Porta, Fulvio ;
Facchetti, Fabio ;
Notarangelo, Luigi D. ;
Dusi, Stefano ;
Badolato, Raffaele .
BLOOD, 2007, 109 (11) :4716-4723
[9]  
DORNE J, 2002, CYTOKINE, V18, P98
[10]   Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation [J].
Dupont, Peter J. ;
Warrens, Anthony N. .
IMMUNOLOGY, 2007, 120 (01) :133-139